510(k) K170147

Lucica Glycated Albumin-L by Asahi Kasei Pharma Corporation — Product Code LCP

K170147 is an FDA 510(k) premarket notification submitted by Asahi Kasei Pharma Corporation for the device "Lucica Glycated Albumin-L". The FDA issued a decision of Substantially Equivalent on October 12, 2017. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 12, 2017
Date Received
January 17, 2017
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Assay, Glycosylated Hemoglobin
Device Class
Class II
Regulation Number
864.7470
Review Panel
HE
Submission Type